BioCardia, Inc. Common Stock (BCDA) is a publicly traded Healthcare sector company. As of July 11, 2026, BCDA trades at $0.94 with a market cap of $13.28M and a P/E ratio of -0.76. BCDA moved +3.93% today. Year to date, BCDA is -26.82%; over the trailing twelve months it is -62.20%. Its 52-week range spans $0.78 to $3.20. Analyst consensus is buy with an average price target of $15.50. Rallies surfaces BCDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover BCDA: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $15.50.
| Metric | Value |
|---|---|
| Price | $0.94 |
| Market Cap | $13.28M |
| P/E Ratio | -0.76 |
| EPS | $-1.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.20 |
| 52-Week Low | $0.78 |
| Volume | 540.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-8.23M |
| Gross Margin | 0.00% |
2 analysts cover BCDA: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.50.